Combining Celecoxib and Ibuprofen: Not Recommended

Risks Associated with Combination Therapy

Using multiple NSAIDs simultaneously increases the risk of GI complications beyond what either drug causes alone, with elderly patients facing a 2-3.5-fold increased risk of GI complications 1
The combination of celecoxib and ibuprofen increases the risk of cardiovascular risks including myocardial infarction, stroke, worsening hypertension, and heart failure, as well as renal adverse effects, including volume-dependent renal failure, interstitial nephritis, and nephrotic syndrome 1
Approximately 2% of persons stop NSAIDs due to renal complications with single-agent therapy; dual therapy would increase this risk 1

Choose one NSAID based on the patient's cardiovascular and GI risk profile, and use the lowest effective dose for the shortest duration necessary, as recommended by the American College of Rheumatology 2, 3, 4
Consider acetaminophen (paracetamol) as an adjunct for supplemental analgesia beyond a single NSAID, and for severe pain unresponsive to a single NSAID, consider opioid analgesics rather than adding a second NSAID 1

Add a proton pump inhibitor to reduce GI bleeding risk by 75-85% in high-risk NSAID users, as recommended by the American College of Rheumatology 1, 5
The American College of Rheumatology strongly recommends using either a COX-2 selective inhibitor or a nonselective NSAID in combination with a proton pump inhibitor for patients with a history of symptomatic or complicated upper GI ulcer 5
If the patient is taking low-dose aspirin, use a nonselective NSAID other than ibuprofen in combination with a proton pump inhibitor, as ibuprofen interferes with aspirin's ability to irreversibly acetylate the platelet COX-1 enzyme 2, 3, 5, 6

Monitor blood pressure regularly, as NSAIDs increase mean BP by approximately 5 mmHg, and consider periodic assessment of renal function, especially in high-risk patients 1
Monitor for signs of GI bleeding or ulceration, and be alert for symptoms of cardiovascular thrombotic events including chest pain, shortness of breath, weakness, or slurring of speech 1